Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Fulcrum Therapeutics, Inc.

NASDAQ: FULC · Life Sciences · 2 alerts · CIK 1680581

Share price
$3.71Close, Nov 16
Market cap
$283M
Shares outstanding
76.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Fulcrum Therapeutics, Inc. filings on SEC EDGAR ↗

4:11 PM ET 8-K
M&A Deal

Fulcrum Therapeutics Signs $7M M&A Deal with Slate Medicines, Inc.

Fulcrum Therapeutics entered into an agreement to sell its early-stage fetal hemoglobin (HbF) assets to an unaffiliated third-party pharmaceutical company for $7.0 million in cash. The sale is a strategic update to its pending merger with Slate Medicines, as the proceeds will be credited to Fulcrum's net cash and are expected to increase the cash dividend declared in connection with the merger.

Value
$7M
Counterparty
Slate Medicines, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.